Last Updated:
The GMP of the Asston Pharmaceuticals IPO stands at 24.39%, indicating strong sentiment among investors.
Asston Pharmaceuticals IPO GMP Today.
Asston Pharmaceuticals IPO GMP Day 3: The initial public offering of Asston Pharmaceuticals Ltd has been closed today, Friday, July 11. The price band of the BSE SME IPO, which aims to raise Rs 27.56 crore, has been fixed at Rs 123 apiece. On the last day of bidding on Friday, the issue received a 186.55 times subscription, garnering bids for 27,85,17,000 shares as against the 14,93,000 shares on offer.
The retail and NII participation stood at 172.06x and 353.14x, respectively. The QIB category also received a 85.76x subscription.
The IPO’s grey market premium (GMP) stood at 24.39%, indicating strong sentiment among investors.
The three-day IPO was opened on July 9.
Asston Pharmaceuticals Limited, founded in 2019, is a global exporter of FDA-certified pharmaceutical products across diverse therapeutic categories, operating through direct sales and contract manufacturing.
Asston Pharmaceuticals IPO GMP Today
According to market observers, unlisted shares of Asston Pharmaceuticals Ltd are currently trading at Rs 153 against its upper IPO price of Rs 123. It means a grey market premium or GMP of Rs 30, which is 24.39% over its issue price, indicating strong listing gains.
The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Asston Pharmaceuticals IPO Price And Lot Size
The price of the IPO has been fixed at Rs 123 apiece.
Its minimum lot size is 1,000. It means investors will have to apply for a minimum of 1,000 shares or in multiple thereof.
Retail investors require a minimum capital of Rs 2,30,000 to apply for the IPO.
Asston Pharmaceuticals IPO Allotment And Listing Dates
The basis of allotment of the Asston Pharmaceuticals IPO will be finalised on Monday, July 14.
Shares of Asston Pharmaceuticals Ltd will be listed on the BSE SME platform on July 16.
Asston Pharmaceuticals IPO: More Info
The IPO, which is a bookbuilding of Rs 27.56 crore, is entirely a fresh issue of 22.41 lakh shares.
Asston Pharma’s revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
Sobhagya Capital Options Ltd is the book-running lead manager of the Asston Pharmaceuticals IPO, while Maashitla Securities Private Limited is the registrar for the issue.The market maker for Asston Pharmaceuticals IPO is JSK Securities and Services Private Limited.
Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to personal finance, markets, economy and companies. Having over a decade of experience in financial journalism, Haris h…Read More
Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to personal finance, markets, economy and companies. Having over a decade of experience in financial journalism, Haris h… Read More
view comments
- First Published:
